Gruppo Italiano di Studio sullo Stent nelle Occlusioni Coronariche—supported by GISE (Societa Italiana di Cardiologia Invasiva) - GISSOC II-GISE


Although drug-eluting stents (DES) are frequently used following successful canalization of chronic total coronary occlusions (CTOs), randomized data to support this approach are scarce. Accordingly, the GISSOC II trial sought to compare outcomes after sirolimus-eluting stents (SES) versus bare-metal stent (BMS) implantation in patients with CTOs.